Increased levels of interleukin-6 and matrix metalloproteinase-9 are of cardiac origin in acute coronary syndrome
Authors:
- Ning RenNRNing Ren
- Ji-Bing DuJDJi-Bing Du
- Mei ZhangMZMei Zhang
- Hong-Liang CongHCHong-Liang Cong
- Ti-Gang HuangTHTi-Gang Huang
- 1 January 2007
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Cardiovascular Journal
- Vol. 41 (3) , 149-154
Abstract
To investigate the association between inflammatory mediators, matrix degrading enzymes and acute coronary syndrome (ACS) and the impact of early reperfusion therapy on circulating biomarkers. Peripheral serum levels of interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP) and matrix metalloproteinase-9 (MMP-9) were determined in 134 patients with ACS. These biomarkers were serially monitored in ten patients with intravenous thrombolytic therapy (IVT). Serum levels of IL-6, hs-CRP and MMP-9 were higher in unstable angina (UA) and myocardial infarction (MI) groups than in control or SA group (p<0.05). Peripheral IL-6 level in patients with MI was greater after percutaneous coronary intervention (PCI) (p<0.01) or IVT (p<0.05). Serial concentration determination revealed marked elevation of serum IL-6 and MMP-9 levels, both reaching peak values (like creatine kinase-MB). Elevated levels of IL-6, hs-CRP and MMP-9 provide a link between inflammation, matrix degradation and the development and progression of ACS. IL-6 and MMP-9 appear to be released mainly from vulnerable plaque or necrotic myocardium during the acute phase of MI.Keywords
This publication has 21 references indexed in Scilit:
- Comparison of Levels of Serum Matrix Metalloproteinase-9 in Patients With Acute Myocardial Infarction Versus Unstable Angina Pectoris Versus Stable Angina PectorisThe American Journal of Cardiology, 2006
- Matrix metalloproteinases and cardiovascular diseaseThe opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.European Heart Journal, 2005
- Peripheral levels of matrix metalloproteinase‐9, interleukin‐6, and C‐reactive protein are elevated in patients with acute coronary syndromes: Correlations with serum troponin IClinical Cardiology, 2005
- Effects of interleukin-6 produced in coronary circulation on production of C-reactive protein and coronary microvascular resistanceThe American Journal of Cardiology, 2005
- C-Reactive ProteinCirculation, 2004
- Inflammation in atherosclerosisNature, 2002
- Interfering with healing: the benefits of intervention during acute myocardial infarctionHeart, 2001
- Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6European Heart Journal, 2000
- Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarctionJACC, 2000
- Intravenous streptokinase in evolving acute myocardial infarctionThe American Journal of Cardiology, 1984